263 related articles for article (PubMed ID: 28685597)
21. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
Ziakas PD; Kourbeti IS; Mylonakis E
Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
[TBL] [Abstract][Full Text] [Related]
22. Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Busca A; Candoni A; Audisio E; Passera R; Bruno B; Monaco F; Mordini N; Vacca A; Delia M; Aversa F; Pagano L
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2214-2219. PubMed ID: 27667012
[TBL] [Abstract][Full Text] [Related]
23. Delphi-based study and analysis of key risk factors for invasive fungal infection in haematological patients.
Vázquez L; Salavert M; Gayoso J; Lizasoaín M; Ruiz Camps I; Di Benedetto N;
Rev Esp Quimioter; 2017 Apr; 30(2):103-117. PubMed ID: 28198173
[TBL] [Abstract][Full Text] [Related]
24. Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).
Boğa C; Bolaman Z; Çağırgan S; Karadoğan İ; Özcan MA; Özkalemkaş F; Saba R; Sönmez M; Şenol E; Akan H; Akova M
Turk J Haematol; 2015 Jun; 32(2):100-17. PubMed ID: 26316478
[TBL] [Abstract][Full Text] [Related]
25. Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation.
Marks DI; Liu Q; Slavin M
Expert Rev Anti Infect Ther; 2017 May; 15(5):493-502. PubMed ID: 28335642
[TBL] [Abstract][Full Text] [Related]
26. Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
Pomares H; Arnan M; Sánchez-Ortega I; Sureda A; Duarte RF
Mycoses; 2016 Aug; 59(8):516-9. PubMed ID: 27027972
[TBL] [Abstract][Full Text] [Related]
27. A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients.
Leonart LP; Tonin FS; Ferreira VL; Penteado STS; Wiens A; Motta FA; Pontarolo R
J Clin Pharm Ther; 2017 Oct; 42(5):530-538. PubMed ID: 28620958
[TBL] [Abstract][Full Text] [Related]
28. [Invasive fungal infection management in patients with hematological malignancies].
Kanda Y
Rinsho Ketsueki; 2022; 63(9):1270-1278. PubMed ID: 36198553
[TBL] [Abstract][Full Text] [Related]
29. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
[TBL] [Abstract][Full Text] [Related]
30. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
[TBL] [Abstract][Full Text] [Related]
31. Clinical Spectrum, Diagnosis and Outcome of Rare Fungal Infections in Patients with Hematological Malignancies: Experience of 15-Year Period from a Single Tertiary Medical Center.
Hardak E; Fuchs E; Geffen Y; Zuckerman T; Oren I
Mycopathologia; 2020 Apr; 185(2):347-355. PubMed ID: 32100219
[TBL] [Abstract][Full Text] [Related]
32. Managing invasive fungal infection in hematopoietic stem-cell transplantation.
Sinkó J; Bryan J
Future Microbiol; 2010 Sep; 5(9):1309-14. PubMed ID: 20860477
[TBL] [Abstract][Full Text] [Related]
33. Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients.
Wirk B; Wingard JR
Mycopathologia; 2009 Dec; 168(6):299-311. PubMed ID: 19247798
[TBL] [Abstract][Full Text] [Related]
34. The Changing Epidemiology of Invasive Fungal Infections.
Enoch DA; Yang H; Aliyu SH; Micallef C
Methods Mol Biol; 2017; 1508():17-65. PubMed ID: 27837497
[TBL] [Abstract][Full Text] [Related]
35. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
Maertens J
Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
[TBL] [Abstract][Full Text] [Related]
36. Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.
Miceli MH; Churay T; Braun T; Kauffman CA; Couriel DR
Mycopathologia; 2017 Jun; 182(5-6):495-504. PubMed ID: 28124219
[TBL] [Abstract][Full Text] [Related]
37. 2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan.
Ko BS; Chen WT; Kung HC; Wu UI; Tang JL; Yao M; Chen YC; Tien HF; Chang SC; Chuang YC; Lin DT; ; ; ; ; ;
J Microbiol Immunol Infect; 2018 Jun; 51(3):287-301. PubMed ID: 28781151
[TBL] [Abstract][Full Text] [Related]
38. [Prophylactic strategies for invasive fungal infections after allogeneic hematopoietic stem cell transplantation].
Asano-Mori Y
Rinsho Ketsueki; 2016; 57(10):2208-2217. PubMed ID: 27795532
[TBL] [Abstract][Full Text] [Related]
39. Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients.
Bays DJ; Thompson GR
Infect Dis Clin North Am; 2019 Jun; 33(2):545-566. PubMed ID: 31005138
[TBL] [Abstract][Full Text] [Related]
40. [Invasive Mold Infections in Patients with Hematologic Malignities: The Effects of Environmental Factors].
Atilla A; Çelik M; Çolak ÖY; Kuruoğlu T; Temoçin F; Kelkitli E; Birinci A
Mikrobiyol Bul; 2022 Apr; 56(2):315-325. PubMed ID: 35477233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
